Stockreport

Scilex Holding Company Announces that It Will Be Filing Today of a Supplemental New Drug Application with the FDA for ELYXYB® in Acute Pain Indication [Yahoo! Finance]

Scilex Holding Company  (SCLX) 
PDF ELYXYB ® , a rapid onset and ready-to-use formulation of Celecoxib, delivers a first line non-opioid therapeutic alternative to habit-forming opioids and acetaminophen, [Read more]